Composition
- Active ingredients
- ISOPROTERENOL HYDROCHLORIDE 15MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ISOPROTERENOL HYDROCHLORIDE 1% · SolutionNDA006327-003 · Discontinued
- ISOPROTERENOL HYDROCHLORIDE 0.5% · SolutionNDA006327-002 · Discontinued
- ISOPROTERENOL HYDROCHLORIDE 0.103MG/INH · Aerosol, meteredNDA011178-001 · Discontinued
- ISOPROTERENOL HYDROCHLORIDE 10MG · TabletNDA006328-001 · Discontinued
- ISOPROTERENOL HYDROCHLORIDE 15MG · TabletThis page
- ISOPROTERENOL HYDROCHLORIDE 0.2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA010515-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA006328.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Isuprel
- Active substance
- isoproterenol hydrochloride
- Route
- Rectal, Under the tongue
- Dosage form
- Tablet
- Applicant
- Sanofi Aventis US
- Status
- Discontinued
- FDA approval
- 19 Feb 1948
- Application
- NDA006328-002



